ARS Pharmaceuticals (NASDAQ:SPRY) Stock Price & Analysis

–

USD

–(–)

Open

$8.60

Prev. Close

$5.06

High

$8.62

Low

$8.18

Company Profile

ARS Pharmaceuticals, Inc. specializes in creating ARS-1, an innovative intranasal epinephrine spray utilizing advanced absorption technology. This product serves as a crucial intervention for individuals and their households who are susceptible to life-threatening allergic reactions caused by food, pharmaceuticals, or insect stings. Among its offerings is Neffy, a low-dose version of its intranasal epinephrine nasal spray. Established in 2015, the firm operates out of San Diego, California.

CEODonn Casale

SectorHealthcare

IndustryBiotechnology

Employees195

IPO DateDec 4, 2020

ExchangeNASDAQ

Exchange NameNASDAQ Global Market

CurrencyUSD

Headquarters & Contact

Address11682 El Camino Real

City / State / ZIPSan Diego, CA, 92130

CountryUnited States

Phone858 335 1300

Websitehttps://ars-pharma.com

ARS Pharmaceuticals, Inc.

Company Profile

Recently from Cashu